I don't think that there is any compelling evidence to support a...

I don't think that there is any compelling evidence to support a CR in this current or in the next quarter.
I do recall management responding to this very topic in no uncertain terms stating that they believed
funds were adequate to see the Co through to the completion of this current trial. After that, and with
successful trial results, who cares, as the SP will be in multiples above the current level...but of course,
there is that one caveat "successful trial results" that's required.